M. Suedkamp et al., Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA, AM HEART J, 138(2), 1999, pp. 269-272
Citations number
23
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective To determine if end-stage dilated cardiomyopathy (DCM) is associa
ted with the presence of Lyme disease causing spirochete Borrelia burgdorfe
ri in the myocardium, we used nested polymerase chain reaction to detect B
burgdorferi DNA in myocardial samples from explanted hearts of patients wit
h end-stage DCM. patients originated from endemic areas for Lyme disease (B
avaria, Lower Saxony, Germany).
Methods and Results This was a retrospective study. Polymerase chain reacti
on was used to detect the specific B burgdorferi recombinant outer surface
protein A (OspA) gene in myocardial tissue from 68 patients with end-stage
DCM who had undergone heart transplantation. The clinical history of lyme d
isease, the presence of Borrelia burgdorferi OspA, and antibodies against O
spA in myocardial tissue and serum were investigated. B burgdorferi DNA was
not detected in an of the 68 human hearts. Immunoglobulin G antibodies aga
inst specific B burgdorferi antigens were observed in 3 (12.5%) of 24 patie
nts. In contrast, 4 hearts from rats experimentally infected with B burgdor
feri were all positive for OspA DNA as measured by polymerase chain reactio
n.
Conclusion Our data show that cardiac myocytes of hearts obtained from subj
ects with end-stage DCM did not contain B burgdorferi DNA as investigated b
y polymerase chain reaction. However, B burgdorferi shows a high affinity f
or myocardial tissue as shown by the animal studies, indicating that myocar
dial infections are nevertheless possible.